Testosterone Cypionate Injection, USP

Pfizer Inc

Revision date : 2010-02-10

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

202-859-9/100-51-6

Name of the chemical

Benzyl Alcohol

Concentration

<1.0

EC/CAS

204-402-9/120-51-4

Name of the chemical

Benzyl benzoate

Concentration

*

General Information

Version

2.0

Revision date

2010-02-10

Product name

Testosterone Cypionate Injection, USP

Product name

Testosterone Cypionate Injection, USP

Identification on the label/Trade name

Depo-Testosterone

Chemical name

Mixture

1.2.1 Relevant identified uses

Pharmaceutical product used for hormone replacement therapy

Emergency telephone

1-800-424-9300, +44 (0)208 762 8322

Icons in SDS

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

DANGER

Hazard Codes

Hazard statements (CLP)

H351, H360

Hazard statements

Code

Statements

H351

Suspected of causing cancer

Section 2

SECTION 2: Hazards identification

Appearance Liquid

Signal word

DANGER

Hazard statements

May damage fertility or the unborn child. Suspected of causing cancer.

Additional information

Long Term Adverse reproductive effects seen in repeat-dose animal studies are consistent with the pharmacologic action of this drug and are expected to be relevant to humans. Known Clinical Effects Clinical use has caused effects on reproductive system, including prolonged erection (priapism), breast development in males (gynecomastia), loss of libido, decreased sperm count, impairment of male fertility, development of male characteristics (masculinization), development of male characteristics in the female fetus, impairment of female fertility. Clinical use of this drug has caused prostate cancer, liver cancer. EU Indication of danger Toxic to reproduction: Category 1 Carcinogenic: Category 2 EU Hazard Symbols EU Risk Phrases R45 - May cause cancer. R60 - May impair fertility. R61 - May cause harm to the unborn child. Australian Hazard Classification (NOHSC)

Hazardous Ingredients

Non-Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Hazardous Substance. Non-Dangerous Goods. (NOHSC)

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.